Page last updated: 2024-11-06

hydroxyproline and Carcinoma, Non-Small Cell Lung

hydroxyproline has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chung, EJ1
Kwon, S1
Reedy, JL1
White, AO1
Song, JS1
Hwang, I1
Chung, JY1
Ylaya, K1
Hewitt, SM1
Citrin, DE1
Kołaczkowska, M1
Junik, R1
Rzymkowska, M1
Kramer, L1

Trials

1 trial available for hydroxyproline and Carcinoma, Non-Small Cell Lung

ArticleYear
[The effect of chemotherapy on bone metabolism in patients with non-small cell lung cancer].
    Pneumonologia i alergologia polska, 1998, Volume: 66, Issue:5-6

    Topics: Adult; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; B

1998

Other Studies

1 other study available for hydroxyproline and Carcinoma, Non-Small Cell Lung

ArticleYear
IGF-1 Receptor Signaling Regulates Type II Pneumocyte Senescence and Resulting Macrophage Polarization in Lung Fibrosis.
    International journal of radiation oncology, biology, physics, 2021, 06-01, Volume: 110, Issue:2

    Topics: Alveolar Epithelial Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cell Polarity; Cellular Senescen

2021